Skip to main content

Table 2 The effect of simvastatin on expression of genes involved in lipid metabolism in MiaPaCa-2 cells

From: The effect of simvastatin on lipid droplets accumulation in human embryonic kidney cells and pancreatic cancer cells

Gene symbol

Product name and related functional pathway

RefSeq ID

Fold change after simvastatin

FDR

6 μM

12 μM

HMGCS1

3-hydroxy-3-methylglutaryl-coenzyme A synthase (EC 2.3.3.10)

NM_002130.6

3.48

3.63

3.3 × 10-8

 

Mevalonate pathway (cholesterol synthesis)

    

HMGCR

3-hydroxy-3-methylglutaryl-coenzyme A reductase (EC 1.1.1.34)

NM_000859.1

2.58

3.11

2.1 × 10-6

 

Mevalonate pathway (cholesterol synthesis)

    

MVD

Mevalonate pyrophosphate decarboxylase (EC 4.1.1.33)

NM_002461.1

2.31

2.39

3.4 × 10-7

 

Mevalonate pathway (cholesterol synthesis)

    

PPAP2A

Phosphatidic acid phosphatase 2a (EC 3.1.3.4)

NM_003711.2

1.79

2.25

3.3 × 10-5

 

Kennedy pathway (triacylglycerol synthesis)

    

AGPAT2

1-acyl-glycerol-phosphate acyltransferase 2 (EC 2.3.1.51)

NM_006412.3

1.71

2.01

5.0 × 10-5

 

Kennedy pathway (phospholipids and glycerolipids synthesis)

    

ACSS2

Acyl-CoA synthetase short-chain family member 2 (EC 6.2.1.1)

NM_018677.2

2.16

2.22

1.7 × 10-6

 

Activation of long chain fatty acids

    

ABCA7

ABC transporter sub-family A member 7

NM_019112.3

1.67

2.03

2.3 × 10-5

 

Transporter involved in cholesterol and lipid homeostasis

    
  1. Simvastatin used in concentration 6 and 12 μM, 24 hrs exposure. Presented are only transcripts with FC > 2.0 or < 0.5 and FDR < 0.05. For full list of differentially regulated transcripts see the ArrayExpress database, accession number E-MTAB-1501.